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Abstract
Background: In the duplication-degeneration-complementation (DDC) model, a duplicated gene has three
possible fates: it may lose functionality through the accumulation of mutations (nonfunctionalization), acquire a
new function (neofunctionalization), or each duplicate gene may retain a subset of functions of the ancestral gene
(subfunctionalization). The role that promoter evolution plays in retention of duplicated genes in eukaryotic
genomes is not well understood. Fatty acid-binding proteins (Fabp) belong to a multigene family that are highly
conserved in sequence and function, but differ in their gene regulation, suggesting selective pressure is exerted via
regulatory elements in the promoter.
Results: In this study, we describe the PPAR regulation of zebrafish fabp1a, fabp1b.1, and fabp1b.2 promoters and
compare them to the PPAR regulation of the spotted gar fabp1 promoter, representative of the ancestral fabp1
gene. Evolution of the fabp1 promoter was inferred by sequence analysis, and differential PPAR-agonist activation of
fabp1 promoter activity in zebrafish liver and intestine explant cells, and in HEK293A cells transiently transfected
with wild-type and mutated fabp1promoter-reporter gene constructs. The promoter activity of spotted gar fabp1,
representative of the ancestral fabp1, was induced by both PPARα- and PPARγ-specific agonists, but displayed a
biphasic response to PPARα activation. Zebrafish fabp1a was PPARα-selective, fabp1b.1 was PPARγ-selective, and
fabp1b.2 was not regulated by PPAR.
Conclusions: The zebrafish fabp1 promoters underwent two successive rounds of subfunctionalization with respect
to PPAR regulation leading to retention of three zebrafish fabp1 genes with stimuli-specific regulation. Using a
pharmacological approach, we demonstrated here the divergent regulation of the zebrafish fabp1a, fabp1b.1, and
fabp1b.2 with regard to subfunctionalization of PPAR regulation following two rounds of gene duplication.
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Background
Gene duplication is thought to facilitate increasing or-
ganismal complexity, but evolution does not accommo-
date redundancy. Duplication of genes can occur by
unequal crossing-over during meiosis, replication slip-
page, retrotransposition, aneuploidy, or whole genome
duplication [1]. The common fate of duplicated genes is
loss of one copy owing to accumulated mutation and
functional decay (non-functionalization) [2, 3]. Alterna-
tively, both copies of a duplicated gene may be retained
if one of the duplicates acquires a novel function (neo-
functionalization), or the functions of the ancestral gene
are subdivided between the duplicates (subfunctionaliza-
tion) [2–4]. Non-, neo-, and sub-functionalization repre-
sent three possible fates of duplicated genes as described
in the duplication degeneration complementation (DDC)
model [2]. Both mutation of protein coding regions and
the loss or gain of cis-acting regulatory elements in the
promoters of duplicated genes may account for altered
function of duplicated genes. Mutations in regulatory el-
ements of promoters may affect tissue-, developmental
stage- and stimulus-dependent transcript levels of dupli-
cated genes [2–5].
Fatty acid binding proteins (Fabp), which belong to
the multigene family of intracellular lipid-binding pro-
teins, function as carriers of fatty acids, eicosanoids and
other hydrophobic ligands to effectors in the cytosol
and nucleus [6]. Previously, we observed that the pro-
moters of the tandemly duplicated fabp genes of zebra-
fish, fabp1b.1 and fabp1b.2, differ in their regulation by
peroxisome proliferator activated receptors (PPARs),
where fabp1b.1 promoter activity was induced by
PPAR, but fabp1b.2 promoter activity was not induced
by PPAR [7]. The zebrafish fabp1a and fabp1b genes
were generated by duplication of ancestral fabp1 gene
owing to a whole genome duplication (WGD) event
that occurred in the ray-finned teleost lineage approxi-
mately 325 mya [8–11]. Subsequently, the zebrafish
fabp1b.1 and fabp1b.2 genes arose by tandem duplica-
tion of fabp1b, most likely by misaligned cross-over of
homologous chromosomes during meiosis [12–14]. The
zebrafish fabp1b.1 and fabp1b.2 genes are the only tan-
dem duplicates of the multigene family of intracellular
lipid-binding protein genes identified, thus far, in tele-
ost fishes [12]. As a result, the zebrafish genome con-
tains three extant fabp1 genes, fabp1a, fabp1b.1, and
fabp1b.2. Spotted gar (Lepisosteus oculatus, order Lepi-
sosteiformes) belongs to an order of teleost fishes that
did not undergo a WGD, therefore, its genome contains
a single copy of the fabp1 gene.
Zebrafish fabp1b.1 and fabp1b.2 differ in their respon-
siveness to dietary fatty acids: fabp1b.1 mRNA levels are
increased in the intestine of linolenic acid-fed zebrafish,
whereas fabp1b.2 mRNA levels are unaffected by
linolenic acid [14]. Zebrafish fabp1a, fabp1b.1, and
fabp1b.2 also differ in their responsiveness to the non-
selective PPAR agonist, clofibrate [15]. fabp1a mRNA
levels are increased in the liver of clofibrate-fed zebra-
fish, fabp1b.1 mRNA levels are increased in the heart of
clofibrate-fed zebrafish, while fabp1b.2 mRNA levels are
unaffected by clofibrate [15]. These findings implicate
the PPARs in the differential regulation of the fabp1a,
fabp1b.1 and fabp1b.2 genes in zebrafish [14, 15].
PPARs are nuclear receptor transcription factors that
bind, and are activated by, free fatty acids and eicosa-
noids [16–18]. Upon activation, PPARs heterodimerize
with the retinoid X receptor (RXR) and bind to a PPAR
response element (PPRE) located in the promoters of
many vertebrate genes, including fabp genes [16–18].
The consensus sequence for the vertebrate PPRE is de-
fined as 5′-CAAAACAGGTCANAGGTCA-3′ [16–18].
Binding of the PPAR to a PPRE may cause increased
or decreased gene expression, depending on the gene
[16–18]. Three PPAR isoforms have been identified
across vertebrate species: PPARα, PPARγ, and PPARß/
∂ [16–18]. While PPARα and PPARγ are expressed in
many vertebrate tissues, PPARß/∂ expression is limited
to the skin, adipose, and brain [16–18]. A PPRE may
be PPAR isoform-selective (i.e., a PPRE that preferen-
tially binds PPARα relative to PPARγ) [16, 17]. A PPRE
with high sequence identity in the 5′ flanking region (5′
FR) (underlined: 5′-CAAAACAGGTCANAGGTCA-3′)
to the consensus PPRE exhibits greater activation of tran-
scription at promoters by the isoform PPARα compared
to the isoform PPARγ, whereas PPARγ binding is less-
dependent on the 5′FR than PPARα [16–18]. Both PPARα
and PPARγ bind to the direct repeat element (DR1)
(underlined 5′-CAAAACAGGTCANAGGTCA-3′) of the
PPRE to activate transcription [16–18]. A PPRE with low
sequence identity in the 5′FR and high sequence identity
in the DR1, therefore, may be PPARγ-selective [16–18], as
is apparent for fabp1b.1 promoter activity, which displays
PPARγ-selectivity in liver and intestine explant tissue and
fabp promoter-reporter gene constructs in the human em-
bryonic kidney cells, HEK293A [7].
The objective of this study was to investigate diver-
gent, PPAR-dependent transcriptional regulation at the
promoters of the zebrafish (Danio rerio) fabp1a, fabp1b.1
and fabp1b.2 genes, and the spotted gar fabp1 gene (rep-
resentative of the ancestral fabp1 gene) in order to deter-
mine the molecular mechanisms that led to the retention
of the three fabp genes in zebrafish following the teleost-
specific WGD event and subsequent local (tandem) dupli-
cation event. To define teleost fabp1 promoter evolution,
the regulation of zebrafish fabp1a, fabp1b.1, and fabp1b.2
gene promoters was investigated by three approaches: (1)
assay of gene transcripts in liver and intestine explant cul-
tures treated with PPAR-agonists; (2) identification of
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putative PPREs in the zebrafish fabp1a, fabp1b.1, and
fabp1b. and the spotted gar fabp1 promoters by in silico
analysis; and (3) in HEK293A cells using wild-type and
mutagenized zebrafish fabp1a, fabp1b.1, and fabp1b.2,
and spotted gar fabp1 promoters fused to the lucifer-
ase reporter gene, to determine the promoter-specific
regulation of fabp1 genes by PPARα and PPARγ. We
applied a comparative pharmacological approach to
spotted gar fabp1 and zebrafish fabp1a, fabp1b.1, and
fabp1b.2 promoter activity across a wide range of
PPAR agonist concentrations in the absence or pres-
ence of PPAR antagonists. In this way, it was possible
to model evolutionary processes for PPAR isoform-
selectivity through readily quantifiable measurements
of agonist potency, efficacy, and specificity.
Results
Differential induction of zebrafish fabp1a, fabp1b.1 and
fabp1b.2 transcription by PPAR agonists in zebrafish liver
and intestine explant culture
The genomic organization of the fabp1 gene of spotted
gar and, the fabp1a, fabp1b.1 and fabp1b.2 genes of zeb-
rafish is highly conserved; each gene consists of four
exons, they share between 57 – 75 % mRNA sequence
identity (Fig. 1a) and 40 – 71 % amino acid sequence
identity (Fig. 1b), but differ markedly in their promoter
sequences (Fig. 1c). The duplicated zebrafish fabp1 genes
also exhibit differential regulation by linolenic acid and
by the PPAR-agonist, clofibrate [12, 14, 16].
To determine if fabp1a, fabp1b.1 and fabp1b.2 mRNA
levels are induced by PPAR activation, the steady-state
levels of duplicated fabp transcript were quantified in
explant tissue derived from zebrafish liver and intestine
treated with the PPARα agonist, WY14,643, or the
PPARγ agonist, rosiglitazone. fabp1a mRNA transcripts
were detected in both liver and intestine. The PPARα
agonist, WY14,643, increased fabp1a transcript levels
109-fold, while the PPARγ agonist, rosiglitazone, in-
creased fabp1a transcript levels 60-fold. Induction of
fabp1a transcriptional initiation by PPAR agonists was
only in intestine explant tissue and not in liver explant
tissue (Fig. 2). Transcriptional induction of the zebrafish
fabp1a, therefore, appeared to be PPARα-selective as
WY14643 resulted in higher fabp1a mRNA levels than
rosiglitazone treatment (Fig. 2). fabp1b.1 mRNA levels
were increased 13-fold following WY14643 treatment,
and 26-fold following rosiglitazone treatment in liver,
but not intestine (Fig. 2). Based on the differential regu-
lation of these duplicated genes by PPAR agonists,
fabp1b.1 induction appears PPARγ-selective as rosiglita-
zone treatment resulted in higher fabp1b.1 mRNA levels
than WY14643 treatment (Fig. 2). fabp1b.2 mRNA was
detected in both liver and intestine, but the steady-state
level of fabp1b.2 transcripts was not changed in liver or in-
testine explant tissue by either rosiglitazone or WY14643
Fig. 1 Cladograms and comparisons of sequence identity for spotted gar fabp1 and zebrafish fabp1a, fabp1b.1, and fabp1b.2 mRNA (a), amino
acid (b), and promoter (c) sequences. Multiple sequence alignments were conducted using Clustal Omega with default settings. Cladograms of
multiple sequence alignments are shown on the left (zf = zebrafish, sg = spotted gar). Tables shown on the right display percent sequence
identity between genes. Accession files were: fabp1 mRNA: XM_006626498, amino acid: XP_006626561, promoter: Gene ID: 102694982; fabp1a
mRNA: NM_001044712, amino acid: NP_001038177, promoter: Gene ID: 791610; fabp1b.1 mRNA: NM_001024651, amino acid: NP_001019822,
promoter: Gene ID: 554095; fabp1b.2 mRNA: XM_002663048, amino acid: XP_002663094, promoter: Gene ID: 100330224 from National Center for
Biotechnology Information (NCBI) Gene [36]
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treatment (Fig. 2). These data demonstrate that transcrip-
tion of fabp1a and fabp1b.1, but not fabp1b.2, is induced
by PPAR in zebrafish liver and intestine explant tissue.
In silico analyses
Promoter sequences of the zebrafish fabp1a, fabp1b.1,
and fabp1b.2, and spotted gar fabp1 genes, 5′ of their
transcription start sites (TSS), were analyzed in silico for
the presence of putative PPREs. Sequences of 3,308 bp
for zebrafish fabp1a, 3,059 bp for zebrafish fabp1b.1,
3,218 bp for zebrafish fabp1b.2, and 3,283 bp spotted gar
fabp1 were retrieved from databases using the conserved
non-coding sequence (CNS) discovery pipeline (v. 3.0)
[19] (Additional file 1) and putative PPREs identified by
the algorithm, MatInspector (v. 8.1). The length (in bp)
of the promoter fragments retrieved was chosen by the
CNS discovery pipeline as the region within 4,000 bp 5′
upstream of the TSS containing > 60 % of transcription
factor binding motifs with > 60 % sequence identity to
the vertebrate transcription factor binding site [19].
Two putative PPREs were identified in the fabp1a pro-
moter fragment that had 66.7 % and 87.9 % (indicated
by the purple rectangle in Fig. 3) sequence identity to
the consensus sequence for the vertebrate PPRE (5′ –
3′, respectively) (Additional file 1) [16, 17]. Five putative
PPREs were identified in the fabp1b.1 promoter frag-
ment that exhibited 65 %, 68.1 %, 82.3 % (indicated by
the red rectangle in Fig. 3), 65.1 % and 76.2 % sequence
identity to the consensus sequence for the vertebrate
PPRE (5′ – 3′, respectively) (Additional file 1) [16, 17].
No PPREs were identified within the fabp1b.2 promoter
fragment (Additional file 1). The PPRE at −2,710 bp rela-
tive to the TSS in fabp1a displayed high sequence identity
to the PPRE consensus in the 5′FR (5′-CAAAAC-3′), but
not the DR1 (5′-AGGTCANAGGTCA-3′) region of the
Fig. 2 The PPAR-dependent induction of fabp1a and fabp1b.1 mRNA was tissue-specific. Explant liver and intestine cells were cultured for 48 h
before being treated with 1 μM WY14643 (PPARα-specific agonist) or rosiglitazone (PPARγ-specific agonist) for 24 h. fabp1a, fabp1b.1, and fabp1b.2
mRNA levels were quantified by qRT-PCR using the ΔΔCT method and normalized to GAPDH. Data are mean ± SEM. *P < 0.001 compared to vehicle
treatment within tissue and transcript, †P < 0.001 compared to WY14643 treatment within tissue and transcript as determined by two-way ANOVA
followed by Bonferroni’s post-hoc test. n = 4
Fig. 3 Putative PPREs in the zebrafish fabp1a, fabp1b.1 and fabp1b.2,
and spotted gar fabp1 gene promoters. Putative PPREs were
identified using MatInspector (v. 8.1). Approximately 3,000 bp
promoter fragments are shown (scale: bars at 500 bp intervals).
Right-facing arrows indicate the TSS. Gene name is indicated to the
left of each promoter. Coloured rectangles indicate putative PPREs
(sequence, position relative to TSS, and % sequence identity to the
defined vertebrate PPRE consensus sequence below each promoter).
Purple rectangles indicate PPREs that may be PPARα-selective. Red
rectangles indicate PPREs that may be PPARγ-selective. Blue boxes
indicate the 5′FR. Orange boxes indicate the DR1. A possible PPARα-
selective PPRE was identified at −2,710 bp relative to the TSS of the
zebrafish fabp1a promoter. A possible PPARγ-selective PPRE was
identified at −1,232 bp relative to the TSS of the zebrafish fabp1b.1
promoter. No PPREs were identified in the zebrafish fabp1b.2
promoter. Two putative PPREs were identified at −1,953 bp (PPRE-1)
and −539 bp (PPRE-2) relative to the TSS of the spotted gar fabp1
promoter that were PPARα- and PPARγ-selective, respectively.
Complete sequence data are provided in Additional file 1
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PPRE (Additional file 1). In contrast, the PPRE sequence
at −1,232 bp relative to the TSS in fabp1b.1 displayed high
sequence identity to the vertebrate PPRE consensus in the
DR1, but not 5′FR (Additional file 1). The 5′FR of the
PPRE enhances the binding of PPARα to the PPRE and,
thereby, imparts PPARα-selectivity to a PPRE. The 5′ FR
is not required, however, for PPARγ binding to the PPRE
and, thus, is not crucial for PPARγ-dependent gene
regulation [16, 17]. Based on this observation, the puta-
tive PPRE identified at −2,710 bp in the fabp1a pro-
moter appears to be PPARα-selective, whereas the
PPRE at −1,232 bp in fabp1b.1 was PPARγ-selective,
which is consistent with the induction of the steady-
state levels of fabp1a and fabp1b.1 transcripts in zebra-
fish explant intestine cultures treated with PPARα- and
PPARγ-specific agonists (Fig. 2).
Four putative PPREs were identified in the spotted gar
fabp1 promoter that had 75.6 % (indicated by the purple
rectangle in Fig. 3), 64.7 %, 74.3 % (indicated by the red
rectangle in Fig. 3), and 64.8 % sequence identity to the
consensus sequence of the vertebrate PPRE (5′–3′, re-
spectively). Similar to the PPRE in the zebrafish fabp1a
gene, the putative PPRE present at −1,953 bp relative to
the TSS of spotted gar fabp1 displayed high sequence
identity to the PPRE consensus sequence in the 5′FR
(henceforth referred to as PPRE-1). Like the PPRE in
zebrafish fabp1b.1, the putative PPRE at −539 bp relative
to the TSS of spotted gar fabp1 displayed high sequence
identity to the PPRE consensus in the DR1 region
(henceforth referred to as PPRE-2) [16, 17, 20, 21].
Taken together, these data suggest that the spotted gar
fabp1 promoter might be regulated by both PPARα- and
PPARγ-selective PPREs [16, 17, 20, 21]. Furthermore,
these data suggested that the PPREs with preferential
binding affinity for PPARα and PPARγ, respectively, in
the ancestral (spotted gar) fabp1 gene were subdivided
between fabp1a and fabp1b.1 subsequent to the WGD
event that occurred in ray-finned fish.
Analyses of zebrafish fabp1a, fabp1b.1 and fabp1b.2 and
spotted gar fabp1 promoter activity in HEK293A cells
To determine functionality of putative PPREs in the
fabp1a and fabp1b.1 promoters, 3,300 bp of fabp1a and
2,847 bp of fabp1b.1 5′ upstream of their respective TSS
were PCR-amplified from zebrafish genomic DNA and
cloned into the pGL3-Basic promoter-reporter plasmid.
In the pGL3-Basic plasmid, the 3,300 bp of fabp1a and
2,847 bp of fabp1b.1 were fused to the firefly luciferase
gene for functional promoter assays. All promoter frag-
ments displayed similar basal promoter activity to the
TK promoter in HEK293A cells (data not shown). Treat-
ment of HEK293A cells transfected by the zebrafish
fabp1a promoter construct with 1 nM – 1 mM
WY14643 (PPARα agonist) for 24 h induced in fabp1a
promoter activity (Fig. 4a). WY14643-dependent fabp1a
promoter activity was inhibited by the PPARα-selective
antagonist GW6471 [rightward shift in the concentration-
response curve (CRC) and greater EC50] (Table 1, Fig. 4a).
WY14643-dependent fabp1a promoter activity was not
inhibited by the PPARγ-selective antagonist T0070907
(Table 1, Fig. 4a). Treatment of HEK293A cells transfected
with the fabp1a promoter construct with 1 nM – 1 mM
rosiglitazone (PPARγ agonist) for 24 h also increased
fabp1a promoter activity (Fig. 4b). Rosiglitazone-
dependent fabp1a promoter activity was inhibited by
T0070907, but not by GW6471 (Table 1, Fig. 4b).
WY14643 was a more potent PPAR agonist for induction
of fabp1a promoter activity than rosiglitazone, indicating
the zebrafish fabp1a gene contained at least one func-
tional, PPARα-selective, PPRE (Table 1).
Treatment of HEK293A cells transfected by the
fabp1b.1 promoter construct with WY14643 induced
fabp1b.1 promoter activity (Fig. 4c). WY14643-dependent
fabp1b.1 promoter activity was inhibited by GW6471, but
not by T0070907 (Table 1, Fig. 4c). Treatment of
HEK293A cells transfected by the fabp1b.1 promoter con-
struct with rosiglitazone also increased fabp1b.1 promoter
activity (Fig. 4d). Rosiglitazone-induced fabp1b.1 promoter
activity was inhibited by T0070907, but not by GW6471
(Table 1, Fig. 4d). Rosiglitazone was a more potent agonist
of fabp1b.1 promoter activity than WY14643, indicating
that the zebrafish fabp1b.1 promoter contained a func-
tional, PPARγ-selective PPRE (Table 1). Efficacy (Emax) did
not differ between agonists or promoters. Thus, differ-
ences in agonist activity between the fabp1a and fabp1b.1
promoters were attributed to disparate potencies (i.e.
EC50) of the PPAR isoforms acting at the fabp1a and
fabp1b.1 promoter PPREs (Table 1).
Site-directed mutagenesis was used to confirm the
functionality of putative PPREs identified in the zebra-
fish fabp1a and fabp1b.1 promoters. Mutagenesis of the
5′FR was expected to reduce the affinity of PPARα to
the PPRE (i.e. a rightward shift in the CRC), whereas
mutagenesis of the DR1 was expected to generally re-
duce PPAR affinity to the promoter [16–18]. The 5′FR
and DR1 elements of the fabp1a PPRE (−2,710 bp) and
the fabp1b.1 PPRE (−1,232) were individually mutagen-
ized (Fig. 5a, b).
Treatment of HEK293A cells transfected by the fabp1a
Δ5′FR promoter construct with WY14643 shifted the
CRC to the right compared to non-mutated fabp1a
(Table 1, Fig. 5c). Treatment of HEK293A cells trans-
fected with the fabp1a ΔDR1 promoter construct with
WY14643 shifted the CRC to the right compared to
non-mutated fabp1a and fabp1a Δ5′FR (Table 1, Fig. 5c).
Treatment of HEK293A cells transfected by the fabp1a
Δ5′FR promoter construct with rosiglitazone shifted the
CRC compared to non-mutated fabp1a (Table 1, Fig. 5d).
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The CRC was shifted to the right in HEK293A cells
transfected with the fabp1a ΔDR1 promoter construct
and treated with rosiglitazone compared to non-mutated
fabp1a and and fabp1a Δ5′FR (Table 1, Fig. 5d). These
data demonstrate that the PPRE at −2,710 was func-
tional and regulated, in part, by PPARα as mutagenesis
of the 5′FR consistently affected PPAR-dependent induc-
tion of promoter activity [17]. Moreover, the DR1
element of the PPRE is required for the binding of all
PPARs, a finding further supported by the functional-
ity of the PPRE at −2,710 bp of the fabp1a promoter
fragment [16–18].
WY14643 did not change the CRC for promoter activ-
ity in HEK293A cells transfected by the fabp1b.1 Δ5′FR
promoter construct compared to non-mutated fabp1b.1
promoter construct (Table 1, Fig. 5e). WY14643 treat-
ment shifted the CRC to the right in HEK293A cells
transfected by the fabp1b.1 ΔDR1 promoter construct
compared to non-mutated fabp1b.1 promoter (Table 1,
Fig. 5e). Although the EC50 was shifted slightly to the
right, the rosiglitazone produced a potent and fully effi-
cacious response in HEK293A cells transfected by the
fabp1b.1 Δ5′FR promoter compared to non-mutated
fabp1b.1 promoter (Table 1, Fig. 5f ). The rosiglitazone
CRC was shifted to the right in HEK293A cells trans-
fected with the fabp1b.1 ΔDR1 promoter construct by
2.5 orders of magnitude compared to non-mutated
fabp1b.1 promoter (Table 1, Fig. 5e). These observations
provide compelling evidence that the zebrafish fabp1b.1
promoter region contains a functional, PPARγ-selective
PPRE at −1,232 bp as rosiglitazone was a more potent
agonist of PPAR induction of fabp1b.1 promoter activity
than WY14643, and the DR1 element, not the 5′FR, was
the major regulator of PPAR potency in these assays
(Table 1). Since neither mutagenesis of the 5′FR or DR1
in fabp1a or fabp1b.1 abolished transcriptional induc-
tion of these fabp genes by PPAR agonism, and no change
in Emax was observed, additional, functional PPREs are
likely present in both the fabp1a and fabp1b.1 promoters.
Given that both fabp1a and fabp1b.1 promoters con-
tained functional, PPAR subtype-selective PPREs, we
assayed the responsiveness of the orthologous spotted
gar fabp1 gene promoter activity to PPAR isoform-
specific agonisism. A 3,283 bp fragment of the spotted
gar fabp1 promoter, 5′ upstream of its TSS, was PCR-
amplified from spotted gar genomic DNA and cloned
into the pGL3-Basic promoter-reporter plasmid 5′ of
the firefly luciferase gene. Treatment of HEK293A cells
transfected by the fabp1 promoter construct with
WY14643 resulted in a bell-shaped CRC for fabp1 pro-
moter activity (Table 2, Fig. 6a). Co-treatment with
WY14643 and T0070907 did not change CRC of spotted
gar fabp1 promoter activity (Table 2, Fig. 6a). Co-
treatment with WY14643 and GW6471 abolished the
Fig. 4 PPAR antagonism of zebrafish fabp1a and fabp1b.1 promoter activity was PPARα- and PPARγ-selective, respectively. Firefly luciferase activity
driven by the fabp1a (a, b) or fabp1b.1 (c, d) promoters was normalized to Renilla luciferase activity driven by the TK promoter in HEK293A cells
treated with 1 nM – 1 mM WY14643 (PPARα agonist) (a, c) or rosiglitazone (PPARγ agonist) (b, d) ± the PPAR antagonists 240 nM GW6471 (PPARα
antagonist) or 10 nM T0070907 (PPARγ antagonist) for 24 h. Data are mean ± SD. *P < 0.001 compared to fabp1a/TK or fabp1b.1/TK alone as determined
via one-way ANOVA followed by Bonferroni’s post-hoc test. n = 3
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Table 1 Pharmacological characterization of PPAR induction of zebrafish fabp1a and fabp1b.1 promoter activity
fabp1a
WY14643 Rosiglitazone
- GW6471 T0070907 Δ5’FR ΔDR1 - GW6471 T0070907 Δ5’FR ΔDR1
Emax (RLU) 152.80 ± 3.44 152.00 ± 7.80 147.90 ± 5.30 136.7 ± 11.1* 133.4 ± 4.94 152.80 ± 3.43 149.60 ± 3.66 151.70 ± 6.22 135.30 ± 7.11 144.40 ± 2.67




- GW6471 T0070907 Δ5’FR ΔDR1 - GW6471 T0070907 Δ5’FR ΔDR1
Emax (RLU) 152.30 ± 5.57 151.30 ± 4.91 148.7 ± 5.27 146.4 ± 3.52 152.80 ± 7.24 152.30 ± 5.67 148.30 ± 4.87 150.70 ± 7.96 147.80 ± 2.02 178.50 ± 8.68**
EC50 (μM) 0.29 (0.17–0.49) 1.08 (0.86–1.54)* 0.10 (0.07–0.19) 0.67 (0.48–0.95) 28.8 (17.3–48.1)* 0.11 (0.07–0.15)*** 0.11 (0.08–0.15)*** 2.40 (1.39–4.15)**,*** 0.70 (0.56–0.89)** 54.5 (32.9–90.4)**
Data derived from Figs. 4 and 5 presented as the mean ± SEM or 95 % confidence intervals (brackets)
*P < 0.05 compared to WY14643 treatment alone within promoter
**P < 0.05 compared to rosiglitazone treatment alone within promoter
***P < 0.05 rosiglitazone treatment compared to matched WY14643 treatment within promoter, as determined via two-way ANOVA followed by Bonferroni’s












Table 2 Pharmacological characterization of PPAR agonist and antagonist regulation of spotted gar fabp1 promoter activity
WY14643
Upward Slope Downward Slope
- GW6471 T0070907 - GW6471 T0070907
Emax (RLU) 80.6 ± 7.40 97.5 ± 3.78 74.2 ± 9.63 - - -
Emin (RLU) 10.9 ± 4.64 8.86 ± 3.50 8.93 ± 4.72 24.7 ± 4.88** - 21.6 ± 4.13**
EC50 (μM) 0.12 (0.07–0.28) 0.54 (0.43–0.65)* 0.17 (0.05–0.25) 0.69 (0.52–1.1)** – 0.45 (0.22–0.71)**
Rosiglitazone
Upward Slope Downward Slope
- GW6471 T0070907 - GW6471 T0070907
Emax (RLU) 56.3 ± 2.40 57.4 ± 2.44 42.5 ± 4.50 - - -
Emin (RLU) 5.28 ± 4.80 −0.42 ± 2.73 1.21 ± 7.80 - - -
EC50 (μM) 0.009 (0.006–0.017) 0.016 (0.012–0.021) 0.024 (0.021–0.062)* - - -
Data derived from Fig. 6 presented as the mean ± SEM or 95 % confidence intervals (brackets)
*P < 0.05 compared to agonist treatment alone within the upward slope
**P < 0.05 compared to matched treatment between upward and downward slopes, as determined via two-way ANOVA followed by Bonferroni’s post-hoc analysis
for Emax, Emin, or by non-overlapping confidence intervals (EC50). n = 3–4
Fig. 5 PPRE mutagenesis identified sites for PPARα- and PPARγ-selective induction of zebrafish fabp1a and fabp1b.1 promoter activity, respectively.
Site-directed mutagenesis was used to alter the 5′ flanking region (Δ5′FR) or direct repeat element (ΔDR1) PPAR binding sites in the fabp1a (a)
and fabp1b.1 (b) promoter fragments. Firefly luciferase activity driven by the fabp1a (c, d) or fabp1b.1 (e, f) promoters was normalized to Renilla
luciferase activity driven by the TK promoter in HEK293A cells treated with 1 nM – 1 mM WY14643 (PPARα agonist) (c, e) or rosiglitazone (PPARγ
agonist) (d, f) for 24 h. Data are mean ± SD. *P < 0.001 compared to fabp1a/TK or fabp1b.1/TK alone, ^P < 0.001 compared to fabp1a Δ5′FR /TK or
fabp1b.1 Δ5′FR /TK within agonist dose as determined via two-way ANOVA followed by Bonferroni’s post-hoc test. n = 3
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bell-shape of the fabp1 CRC and shifted the slope of the
CRC to the right compared to the upward slope of the
WY14643 CRC (Table 2, Fig. 6a). In contrast to
WY14643, treatment of HEK293A cells (transfected with
the fabp1 promoter) with rosiglitazone resulted in a
concentration-dependent increase in fabp1 promoter ac-
tivity (Table 2, Fig. 6b). The CRC for fabp1 promoter ac-
tivity in cells treated with rosiglitazone was not changed
by co-treatment with GW6471, but was shifted to the
right by co-treatment with T0070907 (Table 2, Fig. 6b).
Based on the results of these functional assays, we con-
clude that spotted gar fabp1 promoter activity was indu-
cible by both PPARα and PPARγ. However, higher
concentrations of WY14643 (PPARα agonist), but not
rosiglitazone (PPARγ agonist), reduced promoter activity
of the spotted gar fabp1 genes suggesting an inhibitory
effect of PPARα. This inhibitory effect of the PPARα
agonist may be mediated by recruitment of a
transcriptional repressor to the PPRE-bound PPARα. Al-
ternatively, this inhibitory effect may be mediated by
steric hindrance of PPARα (i.e. a non-specific cross-
activation of PPARγ at high concentrations of WY1463).
The two putative PPREs were identified in the spotted
gar fabp1 promoter region, one located at −1,953 bp 5′
upstream of the TSS (PPRE-1), a location similar to the
functional PPRE identified in the zebrafish fabp1a, and a
second PPRE located at −539 bp (PPRE-2), in approxi-
mately the same location of a functional PPRE identified
in the zebrafish fabp1b.1 promoter. Site-directed muta-
genesis was used to confirm the functionality of these
putative PPREs in the spotted gar fabp1 gene. The DR1
regions of the PPRE-1 and PPRE-2 were individually
mutagenized (ΔPPRE-1, ΔPPRE-2); both mutagenized
PPREs reduced PPAR-induced promoter activity of the
spotted gar fabp1 promoter (Fig. 6c) [16, 17]. ΔPPRE-1
or ΔPPRE-2 of the spotted gar fabp1 abolished the bell-
Fig. 6 PPAR induction of the spotted gar fabp1 promoter was PPARα- and PPARγ-selective. a,b) Firefly luciferase activity driven by the fapb1 promoter
normalized to Renilla luciferase activity driven by the TK promoter in HEK293A cells treated with 1 nM – 10 μM WY14643 (PPARα agonist) (a)
or rosiglitazone (PPARγ agonist) (b) ± 240 nM GW6471 (PPARα antagonist) or 10 nM T0070907 (PPARγ antagonist) for 24 h. C) Site-directed
mutagenesis was used to alter the DR1 PPAR binding sites of two fabp1 PPREs at −1,953 bp (ΔPPRE-1) or −539 bp (ΔPPRE-2). d, e) Firefly
luciferase activity driven by the fapb1 ‘No mutation’, ΔPPRE-1, or ΔPPRE-2 promoters normalized to Renilla luciferase activity driven by the TK
promoter in HEK293A cells treated with 1 nM – 10 μM WY14643 (d) or rosiglitazone (e). Data are mean ± SD. *P < 0.001 compared to agonist
alone or ‘No mutation’, as determined via two-way ANOVA followed by Bonferroni’s post-hoc test. n = 3 – 4
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shaped CRC of promoter activity observed following
WY14643 treatment of the transfected HEK293A cells
(Table 3, Fig. 6d). ΔPPRE-1 or ΔPPRE-2 of fabp1 also
shifted either curve to the right compared to the upward
slope of the non-mutated fabp1 promoter (Table 3,
Fig. 6d). WY14643 induced spotted gar ΔPPRE-1 fabp1
promoter activity much more than the promoter activity
of the spotted gar ΔPPRE-2 fabp1 promoter activity
(Table 3, Fig. 6d). The ΔPPRE-2 fabp1 promoter rosigli-
tazone CRC was shifted to the right compared to the
non-mutated fabp1 promoter (Table 3, Fig. 6e). The
ΔPPRE-1 fabp1 promoter and non-mutated fabp1 pro-
moter displayed similar responses to rosiglitazone
(Table 3, Fig. 6e). We conclude from these functional
promoter assays using the PPARα- and the PPARγ-
specific agonists, that PPRE-1 on the spotted gar fabp1
promoter was PPARα-selective and mediated both in-
creases (concentrations of PPAR agonist < 100 nM) and
decreases (concentrations of PPAR agonist > 100 nM) in
promoter activity. PPRE-2 was PPARγ-selective.
Discussion
In this study, we employed a pharmacological approach
to define the PPAR selectivity, potency, and efficacy of
PPAR-dependent regulation in the promoters of the zeb-
rafish fabp1a, fabp1b.1 and fabp1b.2 genes. We observed
that the zebrafish fabp1a promoter contained a functional,
PPARα-selective PPRE, while the zebrafish fabp1b.1 pro-
moter contained a functional, PPARγ-selective PPRE. The
spotted gar fabp1 promoter contained two functional
PPREs: a PPARα-selective PPRE (PPRE-1) and a PPARγ-
selective PPRE (PPRE-2). These results are consistent with
previously published conclusions that: (1) the steady-state
level of fabp1a and fabp1b.1 mRNA and hnRNA levels
are induced in adult zebrafish fed a linolenic acid- or
clofibrate-rich diets, and this transcriptional activation is
mediated by PPAR [14, 15], and (2) that the fabp1a and
fabp1b.1 promoters are functionally-selective for PPARα
and PPARγ, respectively as described here and in a previ-
ous report [7].
The spotted gar fabp1 promoter served as a represen-
tative of the ancestral fabp1 gene that gave rise to
fabp1a and fabp1b following the teleost WGD [9]. The
two functional PPREs identified in the spotted gar fabp1
promoter were oriented such that PPRE-1 was PPARα-
selective and PPRE-2 was PPARγ-selective. Pharmaco-
logical analyses and site-directed mutagenesis demon-
strated that both the spotted gar PPRE-1 of fabp1 and
the similarly-aligned zebrafish PPRE of fabp1a (Fig. 1)
were more responsive to PPARα-agonists and antago-
nists than to PPARγ-agonists and antagonists, based on
promoter activity assays, suggesting that the fabp1a
PPRE at −1,953 bp was derived from the PPARα-
selective PPRE-1 in the ancestral fabp1 prior to the tele-
ost WGD. Furthermore, pharmacological analyses and
site-directed mutagenesis demonstrated that both the
PPRE-2 of spotted gar fabp1 and the similarly-aligned
zebrafish PPRE of fabp1b.1 (Fig. 1) were both more re-
sponsive to PPARγ agonists and antagonists than to
PPARα agonists and antagonist as assayed by the induc-
tion of promoter activity, suggesting that the fabp1b.1
PPRE at −539 bp was derived from an ancestral
PPARγ-selective PPRE-2 present in the spotted gar (an-
cestral) fabp1 gene prior to its duplication following
the teleost WGD.
Previous studies have focused on non-quantitative or
semi-quantitative data derived from electrophoretic mo-
bility shift assays to determine the specificity of PPARs
interaction with PPREs [16–18, 22]. The unique pharma-
cological approach used in this study to define the
Table 3 Pharmacological characterization of spotted gar fabp1 promoter PPRE mutants
WY14643
Upward Slope Downward Slope
No mutation ΔPPRE-1 ΔPPRE-2 No mutation ΔPPRE-1 ΔPPRE-2
Emax (RLU) 101 ± 2.56 70.6 ± 2.17* 102 ± 8.65 - - -
Emin (RLU) 1.32 ± 2.91 –1.64 ± 3.08 –17.4 ± 18.2 27.6 ± 4.76** - -
EC50 (μM) 0.013 (0.004–0.023) 0.045 (0.032–0.064)* 0.028 (0.008–0.098) 0.38 (0.20–0.41)** - -
Rosiglitazone
Upward Slope Downward Slope
No mutation ΔPPRE-1 ΔPPRE-2 No mutation ΔPPRE-1 ΔPPRE-2
Emax (RLU) 64.9 ± 2.34 61.9 ± 6.66 62.1 ± 5.07 - - -
Emin (RLU) −7.47 ± 3.79 1.17 ± 0.05 2.94 ± 4.03 - - -
EC50 (μM) 0.008 (0.003–0.019) 0.003 (0.001–1.34) 0.18 (0.08–0.36)* - - -
Data derived from Fig. 6 presented as the mean ± SEM or 95 % confidence intervals (brackets)
*P < 0.05 compared to agonist treatment alone within the upward slope
**P < 0.05 compared to matched treatment between upward and downward slopes, as determined via two-way ANOVA followed by Bonferroni’s post-hoc analysis
for Emax, Emin, or by non-overlapping confidence intervals (EC50). n = 3
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regulation and its evolution of promoter activity pro-
vided quantitative data, which supports the contention
that the 5′FR is directly involved in PPARα-, but not
PPARγ-, dependent promoter activation [17]. Further-
more, this work supports earlier findings that the DR1
regulates general PPAR-dependent promoter activation
[16–18, 22].
The data reported here raise two questions. First, how
did the divergent transcriptional regulation of the zebra-
fish fabp1a, fabp1b.1, and fabp1b.2 genes by PPARs
arise? Second, why was this divergent regulation of
fabp1a, fabp1b.1, and fabp1b.2 by PPARs not selected
against? To answer these questions, we must consider
the data from this study and how it might be integrated
into the existing model of gene duplication, particularly
in teleost fishes. The spotted gar fabp1 gene, used here
as a surrogate for the ancestral fabp1 gene promoter,
contained at least two functional PPREs that resembled
the zebrafish fabp1a and fabp1b.1 promoter PPREs, re-
spectively, in both their location relative to the TSS, and
their PPAR-isoform selectivity. The existing model of
gene duplication in teleosts suggests that zebrafish fabp1a
and ancestral fabp1b genes arose by WGD [9, 12, 14],
whereas the zebrafish fabp1b.1 and fabp1b.2 arose by tan-
dem duplication of the fabp1b gene during misaligned un-
equal crossing over during meiosis [12]. From these data,
we can construct a model for divergent regulation of the
fabp1 genes within the context of the DDC model (Fig. 7)
[2–4]. The most straightfoward explanation for the reten-
tion of fabp1a, fabp1b.1 and fabp1b.2 in the zebrafish gen-
ome is the ancestral teleost fabp1 gene was duplicated
during a WGD event, which was later followed by a tan-
dem duplication specific to zebrafish. We showed here
that increasing concentrations of the PPARα-selective
agonist, WY14643, enhanced and then repressed spotted
gar fabp1 promoter activity (Fig. 6). While one might in-
voke recruitment of a transcriptional repressor of the
spotted gar fabp1 promoter activity, this is not the most
parsimonious explanation. Elimination of either PPRE-1
or PPRE-2 abolished the biphasic response of spotted gar
fabp1 promoter activity suggesting PPARα-dependent
functional antagonism of the spotted gar fabp1 promoter
activity, which occurred via an interaction or competition
between the two identified functional PPREs (Fig. 6). No
functional antagonism was observed in the zebrafish
fabp1a and fabp1b.1 promoters (Fig. 5). We suggest that
following the teleost WGD, mutations may have accumu-
lated independently in the PPARα-selective PPRE of the
zebrafish fabp1a promoter, and in the PPARγ-selective
PPRE of the zebrafish fabp1b promoter, leading to elimin-
ation of these elements in their respective promoters and
loss of the functional antagonism observed in the spotted
gar fabp1 promoter (Fig. 7). Zebrafish fabp1a and fabp1b
promoters, therefore, underwent subfunctionalization
relative to fabp1 with regard to PPAR isoform specificity.
Subsequent tandem duplication of the zebrafish fabp1b
gene resulted in a PPARγ-selective PPRE in fabp1b.1 and
the loss of a functional PPRE in the zebrafish fabp1b.2
promoter with retention of basal promoter activity (Fig. 7)
[7]. Zebrafish is unique among teleosts for having three
fabp1 genes [12]. These data demonstrate that fabp1a and
fabp1b.1 genes have retained their functional regulation
by PPAR, and therefore their association with PPAR-
dependent metabolic and hormonal signaling pathways
[16]. In contrast, the local (tandem) duplicate fabp1b.2 is
retained in the genome, but its transcription is not modu-
lated by either dietary fatty acids or PPAR agonists. As
such, the zebrafish fabp1b.2 gene does not appear to be
Fig. 7 PPAR subfunctionalization of the fabp1 promoters following the teleost whole genome duplication. An ancestral fabp1 promoter contained
two PPREs that had high sequence identity to the consensus sequence for PPREs. These PPREs were retained in the spotted gar fabp1 gene promoter.
In zebrafish, fabp1a and the ancestral fabp1b underwent subfunctionalization. fabp1a retained the PPARα-selective PPRE and fabp1b retained the
PPARγ-selective PPRE, following whole genome duplication. Further subfunctionalization of promoter function occurred following the tandem gene
duplication of zebrafish fabp1b resulting in fabp1b.1 and fabp1b.2. Passage of time and accumulation of mutations is represented from left to right.
PPREs are represented by purple (1, α) or red (2, γ) rectangles. PPRE loss is represented by smaller, more transparent rectangles. zf, zebrafish; sg, spotted
gar; WGD, whole genome duplication; TGD, tandem gene duplication
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associated with PPAR-dependent physiological processes
[7, 12, 14]. This conclusion is consistent with cross-species
analyses that have shown genes retained from WGD
events often belong to signalling networks, whereas local
gene duplication events are more likely to acquire
network-independent functions [23, 24]. Additional re-
search is required to understand what other regulatory ele-
ments have undergone neo-, non-, or subfunctionalization
in the zebrafish fabp1 promoters compared to the spotted
gar fabp1 promoter [3, 4, 25–28]. Our observations pro-
vide an example of increasing intra-organismal complexity
through the subfunctionalization of response to PPAR
stimuli among gene duplicates.
Conclusions
The present subfunctionalized state of PPAR respon-
siveness in the zebrafish fabp1a, fabp1b.1, and
fabp1b.2 promoters may represent a form of segrega-
tion avoidance such that three gene products sharing
similar function are expressed in different tissues,
under different developmental or environment condi-
tions [27, 28]. These data demonstrate the divergent,
PPAR isoform-specific regulation of zebrafish fabp1a,
fabp1b.1, and fabp1b.2 in relation to their subfunctio-
nalization across evolutionary history using a unique
pharmacological approach.
Methods
Zebrafish and spotted gar fabp1 promoter sequences
Promoter sequences for zebrafish fabp1a, fabp1b.1, and
fabp1b.2 and spotted gar fabp1 genes were obtained
using the CNS Discovery Pipeline (v. 3.0) created and
described by Turco et al. [19]. The source code for the
CNS Discovery Pipeline 3.0 is available for download at
https://github.com/gturco/find_cns with instructions for
installation at (https://github.com/gturco/find_cns/blob/
master/INSTALL.rst) [19]. CNS Discovery Pipeline was
run using default settings except that the filter for pro-
moter regions containing gene-coding regions was re-
moved. The input was the zebrafish Zv9 whole genome
assembly (GenBank Assembly ID GCA_000002035.2)
and spotted gar Linkage group LG2 LepOcu1 repre-
sentative genome assembly (GenBank Assembly ID
GCA_000242695.1, Gene symbol LOC102694982) [29].
The length of promoter fragments retrieved by the
CNS discovery pipeline was determined as the region
within 4,000 bp 5′ of the TSS containing > 60 % se-
quence identity to the consensus of vertebrate tran-
scription factor binding motifs [19]. The resulting
“.fasta” output files for the fabp promoters and their
corresponding genes were used to design PCR primers
to clone fabp promoter fragments (Additional file 1).
Identification of putative PPREs in teleost fabp1
promoters by in silico analysis
Promoter sequences were analyzed for putative PPREs
using MatInspector (v. 8.1) with the Genomatix ElDorado
genomes database and the vertebrate matrix group. The
PPRE was defined as 5′-CAAAACTAGGTCANAGG
TCA-3′ [16–18]. The mismatch threshold was set to 35 %
(i.e. transcription factor sites were identified if they were
65 % similar to the corresponding IUPAC string).
Cell culture
Primary zebrafish cell culture methods were adapted
from Kan et al. [30]. Primary explant cell cultures of
zebrafish liver and intestine were obtained from adult
male fish. Fish were euthanized with tricaine (10 % v/v)
and rinsed with 70 % ethanol in sterile phosphate-
buffered saline (PBS). The liver and intestine were dis-
sected, rinsed once with PBS, and incubated in 0.25 %
trypsin-EDTA (Gibco, Oakville, ON) for 5 min at room
temperature. Tissue was suspended in trypsin-EDTA by
pipette and centrifuged at 500 x g for 5 min at room
temperature. Cells were resuspended in media contain-
ing 50 % Leibovitz’s L-15, 35 % high glucose DMEM,
15 % Ham’s F-12, 5 % FBS, 0.15 g/L sodium bicarbonate,
15 mM HEPES, 0.01 mg/mL bovine insulin, and 50 ng/
mL human EGF (Gibco) and maintained 28 °C, 100 %
atmospheric air on poly-D-lysine-coated cell culture
plates. Primary zebrafish cells were maintained for 48 h
prior to drug treatment. Media was changed daily. All
protocols were in accordance with the guidelines out-
lined by the Canadian Council on Animal Care. All ani-
mal protocols were approved by the Carleton Animal
Care Committee at Dalhousie University prior to start
of this study.
Human embryonic kidney 293A (HEK293A) cells were
obtained from Cedarlane (Burlington, ON). HEK293A
cells were maintained at 37 °C, 5 % CO2 in DMEM con-
taining 10 % FBS and 104 U/mL Pen/Strep. HEK293A
cells express PPARα and γ [31], which was confirmed by
sequencing the RT-PCR products (data not shown).
Cloning of zebrafish fabp1a, fabp1b.1, and fabp1b.2, and
spotted gar fabp1 promoter fragments into the pGL3-
basic plasmid
DNA fragments containing the zebrafish fabp1a, fabp1b.1
and fabp1b.2, and spotted gar fabp1 promoter region were
amplified from genomic DNA by PCR. Genomic DNA
was isolated from frozen liver using the GenElute
Genomic DNA Miniprep kit according to the manu-
facturer’s instructions (Sigma-Aldrich, Oakville, ON).
The PCR contained: 2 mM MgCl2, 0.5 μM forward and
reverse primers (Additional file 2), 0.3 mM dNTPs, 1 U
Taq DNA polymerase, and 40 ng genomic DNA. PCR
conditions were: 95 °C for 10 min; 35 cycles of 95 °C for
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30 s, 57 °C for 30 s, 72 °C for 6 min; and 72 °C for 10 min.
PCR products were resolved by gel electrophoresis and
purified using the GenElute Gel Extraction kit (Sigma-Al-
drich). Purified fabp1a, fabp1b.1, and fabp1b.2 PCR prod-
ucts were digested with MluI and HindIII according to
the manufacturer’s instructions (Fermentas, Burlington,
ON). The purified spotted gar fabp1 PCR product was
ligated into pGEM-T easy vector (Fermentas) at 16 °C
overnight using T4 DNA ligase according to the manufac-
turer’s instructions (Invitrogen, Burlington, ON). The
spotted gar fabp1 promoter fragment was excised from
pGEM-T by digestion with NcoI and SacI according to the
manufacturer’s instructions (Fermentas). fabp1a, fabp1b.1,
and fabp1b.2 PCR products were ligated into pGL3-Basic
(Promega, Madison, WI) at 16 °C overnight using T4
DNA ligase according to the manufacturer’s instructions
(Invitrogen). The resulting plasmids (pfabp1a, pfabp1b.1,
pfabp1b.2, and pfabp1) were propagated in ampicillin-
resistant DH5α competent E. coli (New England Biolabs,
Whitby, ON) and purified using the GenElute Plasmid
Midiprep kit (Sigma-Aldrich). The pHRL-TK plasmid was
obtained from Promega.
pfabp1a, pfabp1b.1, and pfabp1 mutant plasmids were
generated by PCR-based site-directed mutagenesis.
The pfabp1a PPRE 5′FR at −2,710 bp was mutated
from 5′-CAAAAC-3′ to 5′-TGGGGT-3′ and the
PPRE DR1 at −2,710 bp was mutated from 5′-
ACAAGT-3′ to 5′-CGTGGA-3′. The pfabp1b.1 PPRE
5′FR at −1,232 bp was mutated from 5′-CTAAAC-3′
to 5′-TCGGGT-3′ and the PPRE DR1 at −1,232 bp
was mutated from 5′-TAAGGT-3′ to 5′-CGGAAC-3′.
The pfabp1 PPRE-1 (−1,953 bp) was mutated from 5′-
CCCTA-3′ to 5′-TTTCG-3′ and PPRE-2 (−539 bp) was
mutated from 5′-AGGACA-3′ to 5′-TAAAGT-3′. Reac-
tions were composed of 2 mM MgCl2, 0.5 μM forward
and reverse mutagenic primers (Additional file 2), 0.3 mM
dNTPs, 1 U Taq DNA polymerase, and 40 ng plasmid
DNA. PCR conditions were: 95 °C 1 min, 18 cycles of
95 °C 50 s, 60 °C 1 min, and 68 °C 8 min, followed by a
final extension at 68 °C for 10 min. Input plasmid was
removed by digestion with the methylation-insensitive
DpnI (5 U) in 1X FastDigest Green Buffer® in a final
volume of 20 μL (Fermentas, Burlington, ON) for 1 h at
37 °C. The constructs of wild-type and mutagenized zeb-
rafish and spotted gar promoters was confirmed by DNA
sequencing of the promoter-reporter gene constructs
prior to transfection of HEK293A cells (data not shown).
Transfection, PPAR agonist and antagonist treatment, and
the dual luciferase assay
Transfections of HEK293A cells was performed using
lipofectamine 2000 reagent according to the manu-
facturer’s instructions (Invitrogen) with 400 ng of
pfabp1a, pfabp1b.1, pfabp1b.2, pfabp1, or pGL3-Basic
(background control), and 200 ng pHRL-TK. The lu-
ciferase activity of the pHRL-TK plasmid containing
the Renilla luciferase gene under the regulation of
the cytomegalovirus thymidine kinase (TK) promoter
was used to normalize firefly luciferase activity under
the regulation of zebrafish promoters. Luciferase ac-
tivity was quantified according to the manufacturer’s
instructions (Promega).
HEK293A and primary zebrafish cells were treated
with rosiglitazone (PPARγ agonist), WY14643 (PPARα
agonist), T0070907 (PPARγ antagonist), GW 6471 (PPARα
antagonist), or vehicle (0.5 % DMSO) at the concentra-
tions and times indicated [32, 33]. All PPAR agonists and
antagonists were purchased from Sigma-Aldrich.
Quantitative reverse transcriptase PCR
RNA was extracted from HEK239 cells using Trizol®
(Invitrogen). Reverse transcription reactions were carried
out with SuperScript III® reverse transcriptase (+RT;
Invitrogen), or without (−RT) as a negative control for
use in subsequent PCR experiments according to the
manufacturer’s instructions. Two micrograms of RNA
were used per RT reaction. qRT-PCR was conducted
using the LightCycler® system and software (version 3.0;
Roche, Laval, QC). Reactions were composed of a primer-
specific concentration of MgCl2 (Additional file 2), 0.5 μM
each of forward and reverse primers (Additional file 2),
2 μL of LightCycler® FastStart Reaction Mix SYBR Green
I, and 2 μL cDNA to a final volume of 20 μL with dH2O
(Roche). The PCR program was: 95 °C for 10 min, 50 cy-
cles of 95 °C 10 s, a primer-specific annealing temperature
(Additional file 2) for 5 s, and 72 °C for 10 s. Experiments
always included sample-matched –RT controls, a no-
sample dH2O control, and a standard control containing
product-specific cDNA of a known concentration. cDNA
abundance was calculated using the ΔΔCT method and
normalized to GAPDH levels [34].
Statistical analyses
CRCs were fit using non-linear regression analyses [vari-
able slope (four parameters) and Bell-shaped] in Graph-
Pad Prism (v. 5.0). Statistical analyses were conducted by
one-way ANOVA followed by Tukey’s post-hoc test or
two-way ANOVA follow by Bonferroni’s post-hoc test, as
indicated. Homogeneity of variance was confirmed using
Bartlett’s test. All results are reported as the mean ± stand-
ard deviation (SD) or standard error of the mean (SEM),
as indicated, from at least three independent experiments.
Additional files
Additional file 1: Conserved non-coding sequence files (fasta) analyzed
in this study. Putative PPREs are indicated as green 65–74.9 %, yellow 75–
84.9 %, orange > 85 % sequence similarly to the defined PPRE consensus
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sequence. Red indicates primer binding sites for PCR. Light blue indicates
regions of repetitive TAT sequences. DNA sequences determined by
sequencing PCR-cloned promoter fragments of spotted gar or zebrafish
genomic DNA. (PDF 38 kb)
Additional file 2: Table S1. Synthetic oligonucleotides used for cloning
fabp1 (spotted gar), fabp1a (zebrafish), fabp1b.1 (zebrafish), and fabp1b.2
(zebrafish) promoter fragments, mutagenesis of the fabp1, fabp1a, and
fabp1b.1 PPREs, and quantification of fabp1a, fabp1b.1, and fabp1b.2
transcripts via qRT-PCR in this study. (PDF 82 kb)
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